-
Retosiban also
known as GSK-221,149-A is an oral drug
which acts as an
oxytocin receptor antagonist. It is
being developed by
GlaxoSmithKline for the...
- BioTopics.
Retrieved 28 July 2014.
Borthwick AD,
Liddle J (January 2013). "
Retosiban and Epelsiban:
Potent and
Selective Orally available Oxytocin Antagonists"...
-
Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin (ubenimex)...
- (INN)
Retet Rethymic retigabine (INN) Retin-A
retinol (INN)
Retinova retosiban (USAN)
Retrovir Rev-Eyes
revamilast (INN)
revatropate (INN)
revenast (INN)...
-
Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin (ubenimex)...
- hdl:10033/243651. PMID 22709011.
Borthwick AD,
Liddle J (January 2013). "
Retosiban and Epelsiban:
Potent and
Selective Orally available Oxytocin Antagonists"...
-
Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin (ubenimex)...
-
Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin (ubenimex)...
-
blood brain barrier penetration, few
central effects) L-372,662
Nolasiban Retosiban (GSK-221,149) SSR-126,768 WAY-162,720 –
centrally active following peripheral...
-
Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768 WAY-162720
Catabolism inhibitors:
Amastatin Bestatin (ubenimex)...
